(Q36548655)

14 August 2017

1 reference

title

Zoster vaccine live (Oka/Merck). (English)

1 reference

14 August 2017

2

Caroline M Perry

1 reference

14 August 2017

Dean M Robinson

1

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

23

1 reference

14 August 2017

6

1 reference

14 August 2017

525-31; discussion 532-3

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200623060-00007

14 August 2017

0 references

cites work

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

1 reference

12 December 2020

Persistence of immunity to live attenuated varicella vaccine in healthy adults

1 reference

12 December 2020

The role of antivirals in the management of neuropathic pain in the older patient with herpes zoster

1 reference

12 December 2020

Herpes zoster in older adults

1 reference

12 December 2020

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster

1 reference

12 December 2020

The effect of vaccination on the epidemiology of varicella zoster virus

1 reference

12 December 2020

Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

12 December 2020

Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older

1 reference

12 December 2020

Immune response of elderly individuals to a live attenuated varicella vaccine

1 reference

12 December 2020

Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine

1 reference

12 December 2020

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

12 December 2020

Tolerability of treatments for postherpetic neuralgia

1 reference

12 December 2020

Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect

1 reference

12 December 2020

Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology

1 reference

12 December 2020

Postherpetic neuralgia--pathogenesis, treatment, and prevention

1 reference

12 December 2020

Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine

1 reference

12 December 2020

Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002

1 reference

12 December 2020

10.2165/00002512-200623060-00007

Identifiers

DOI

1 reference

PubMed ID

16872235

Dimensions Publication ID

14 August 2017

0 references

1 reference

PubMed ID

16872235